Analysis of the distribution and antibiotic resistance of gram-negative bacilli in sputum of patients with acute exacerbation of chronic obstructive pulmonary disease complicated by type Ⅱ respiratory failure
-
摘要: 目的:探讨慢性阻塞性肺病急性加重(AECOPD)合并Ⅱ型呼吸衰竭患者的气道分泌物中常见革兰阴性杆菌分布与耐药性。方法:回顾性分析2012-01-2013-09我院重症监护室接受机械通气治疗的AECOPD合并Ⅱ型呼吸衰竭患者气道分泌物中病原菌鉴定和药敏监测的结果。结果:69例患者共分离出病原菌104株,其中革兰阴性杆菌为主要致病菌,占78%。鲍曼不动杆菌、铜绿假单胞菌和肺炎克雷伯菌为优势菌群,分别占41.9%、28.4%、12.4%。非发酵菌属细菌对常用抗菌药物的耐药较为普遍,肠杆菌属细菌也逐渐呈现耐药率增高的趋势。结论:AECOPD合并Ⅱ型呼吸衰竭患者的气道分泌物中的病原菌以革兰阴性杆菌的非发酵菌和肠杆菌科为主,在未取得药敏结果之前的初始治疗时采用针对性抗菌治疗较为合理。
-
关键词:
- 慢性阻塞性肺病急性加重 /
- Ⅱ型呼吸衰竭 /
- 革兰阴性杆菌 /
- 耐药性
Abstract: Objective: To analyze the distribution and antibiotic resistance of common gram-negative bacilli in sputum of patients with acute exacerbation of chronic obstructive pulmonary disease complicated by type Ⅱ respiratory failure.Method: A retrospective analysis was done to investigate the sputum pathogens identification and medicine sensitivity in patients with AECOPD complicated by type Ⅱ respiratory failure who receiving mechanical ventilation from January 2012 to September 2013.Result: Total 104 pathogens were isolated from 69 patients,in which Gram-negative bacilli was accounted for 78%.Acinetobacter baumannii,Pseudomonas aeruginosa and Klebsiella pneumoniae were the dominant flora,accounted for 41.9%,28.4%,12.4% respectively.Nonfermenter was generally resistant to common used antibiotics and a gradually increasing tendency of drug-resistance for enteric bacilli was also observed.Conclusion: The non-fermentative bacteria and Enterobacteriaceae are the most common sputum gram-negative bacilli in patients with AECOPD complicated by type Ⅱ respiratory failure.It is more reasonable for target antimicrobial therapy in the initial treatment before getting results of drug sensitivity.-
Key words:
- AECOPD /
- type Ⅱ respiratory failure /
- gram-negative bacilli /
- antibiotic resistance
-
-
[1] Sethi S.Infectious etiology of acute exacerbations of chronic bronchitis[J].Chest,2000,117:S380-385.
[2] Sethi S,Murphy T F.Bacterial infection in chronic obstructive pulmonary disease in 2000:a state-of-the-art review[J].Clin Microbiol Rev,2001,14:336-363.
[3] 蒋旭宏,王原,华军益,等.急诊科C、D类慢性阻塞性肺疾病急性发作患者细菌分布及耐药性分析[J].中华急诊医学杂志,2013,22(6):626-629.
[4] 杨青,俞云松,孙自镛,等.2011年中国CHINET呼吸道病原菌分布和耐药性监测[J].中国感染与化疗杂志,2013,13(5):357-364.
[5] 中华医学会呼吸病学分会慢性阻塞性肺疾病学组.慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17.
[6] 王进军,金迪,熊维宁.Ⅱ型呼吸衰竭患者下呼吸道感染病原菌的分布与耐药性[J].医药导报,2009,28(9):1220-1222.
[7] 向繁,印季.成人呼吸衰竭并下呼吸道感染病原菌分布及耐药性分析[J].中国实用医药,2011,6(9):140-141.
[8] Boixeda R,Rabella N,Sauca G,et al.Microbiological study of patients hospitalized for acute exacerbation of chronic obstructive pulmonary disease (AE-COPD) and the usefulness of analytical and clinical parameters in its identification (VIRAE study)[J].Int J Chron Obstruct Pulmon Dis,2012,7:327-335.
[9] Lin S H,Kuo P H,Hsueh P R,et al.Sputum bacteriology in hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease in Taiwan with an emphasis on Klebsiella pneumoniae and Pseudomonas aeruginosa[J].Respirology,2007,12:81-87.
[10] 丁国正,熊伟.不同年龄组慢性阻塞性肺病患者急性加重期痰培养结果比较[J].临床肺科杂志,2011,16(9):1384-1385.
[11] 朱任媛,张小江,杨启文,等.卫生部全国细菌耐药监测网2011年ICU来源细菌耐药监测[J].中国临床药理学杂志,2012,28(12):905-909.
[12] Bassetti M,Righi E,Esposito S,et al.Drug treatment for multidrug-resisitant Acinetobacter baumannii infections[J].Future Microbiol,2008,3:649-660.
[13] 陈佰义,何礼贤,胡必杰,等.中国鲍曼不动杆菌感染诊治与防控专家共识[J].中华医学杂志,2012,92(2):76-85.
[14] 李耘,吕媛,郑波.卫生部全国细菌耐药监测网2011年度非发酵革兰阴性杆菌耐药监测[J].中国临床药理学杂志,2012,28(12):883-887.
[15] 衣美英,王鹏远,黄汉菊,等.外排泵高表达和外膜蛋白缺乏在铜绿假单胞菌对碳青霉烯类耐药中的作用[J].中华医学杂志,2006,86(7):457-462.
[16] Shen P,Wei Z,Jiang Y,et al.Novel genetic environment of the carbapenem-hydrolyzing beta-lactamase KPC-2 among Enterobacteriaceae in China[J].Antimicrob Agents Chemother,2009,53:4333-4338.
-
计量
- 文章访问数: 350
- PDF下载数: 562
- 施引文献: 0